Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Arrhythmias, Cardiac × Control Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Heart Failure 2 Breast Neoplasms 2 Stomach Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Pheochromocytoma 1 Pain, Postoperative 1 Neoplasms 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1 Leukemia, Myeloid, Acute 1 Gastrointestinal Stromal Tumors 1 Arrhythmias, Cardiac 1 Agnosia 1

Interventions

Population Groups 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06092606 2023-10-23

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

Monyan Pharmaceutical (Shanghai) Co., Ltd.

Phase 2 Unknown

Arrhythmias, Cardiac, Heart Failure, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡